Meghmani Finechem Results Earnings Call for Q4FY23
Conference Call with Meghmani Finechem Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.25-04-2023
25-04-2023
FY23 Annual & Q4FY23 Quarterly Result Announced for Meghmani Finechem Ltd.
Specialty Chemicals Company Meghmani Finechem announced FY23 & Q4FY23 results: FY23: Revenue from operations rose 41% to Rs 2,188 crore as against Rs 1,551 crore in FY22 on account of higher realization compared to last year and volume growth from existing products as well as new products Revenue contribution from derivatives & specialty chemical segment increased to 30% in FY23 vs 25% in FY22 EBITDA grew 35% to Rs 689 crore. Margin stood at 31% in FY23 vs 33% in FY22 on account of the high cost of inventory compared to realization PAT grew 40% to Rs 353 crore as against Rs 253 crore in FY22 and PAT margin stood at 16% (16% in FY22) Net debt/EBITDA stood at 1.3x (1.9x in FY22). Net debt/equity stood at 0.8x (1.3x in FY22) Total debt decreased by Rs 112 crore to Rs 877 crore (Rs 989 crore in FY22) Q4FY23: Volume growth of 15% YoY (13% QoQ) – Led by new product CPVC resin and epichlorohydrin contributed and growth in the volume of caustic soda and hydrogen peroxide Capacity utilization of hydrogen peroxide reached 98% and CMS reached 102% Realization - caustic soda dropped by 23%, chloromethanes dropped by 13% and hydrogen peroxide increased by 1% Revenue grew 13% to Rs 562 crore as compared to Rs 499 crore in Q4FY22 on account of volume growth of 15% Revenue contribution from derivatives & specialty chemical segment increased to 38% in Q4FY23 vs 19% in Q4FY22 PAT stood at Rs 77 crore in Q4FY23 as against Rs 99 crore in Q4FY22 Commenting on the results Maulik Patel, Chairman and Managing Director – MFL, said: “FY 2022-23 was a very exciting year, despite business undergoing through lot of volatility. Realizations were at their peak at the start of the year and dropped sharply by the end of the year. Our strategy to diversify in high-value new products and continuous expansion has brought us volume growth of 15% YoY and 13% QoQ. Revenue contribution from Derivatives & Specialty Chemical segment touched 38% of our revenue in Q4FY23 and our efforts are to further enhance revenue share from this segment. All our future expansion plans are towards this segment.” “Our new expansions that got commissioned in FY23, contributed marginally in FY23, however in the current fiscal (FY24) a sizeable volume growth is expected from these commissioned plants. Further expansions that we are currently working in FY24 will drive growth for FY25 With our focus on continuous expansion and strengthening our integrated complex, we are geared to bring consistent growth to business,” he added. Result PDF25-04-2023
Meghmani Finechem Ltd - 543332 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Meghmani Finechem Limited submits herewith the Press Release for Q4 & FY2023.25-04-2023
Meghmani Finechem Ltd - 543332 - Announcement under Regulation 30 (LODR)-Investor Presentation
Meghmani Finechem Limited submits herewith Investors Presentation for Audited Financial Results - Q4 & FY2023. The said Press Release and Investors Presentation is also available at www.meghmanifinechem.com in the Investor Relations section.25-04-2023
Meghmani Finechem Ltd - 543332 - Audited Financial Results For F.Y. 2022-23.
Meghmani Finechem Limited submits herewith Audited (Standalone and Consolidated) Financial Results of the Company for the Quarter and Year ended on 31st March, 2023 and took on record Auditor's Report thereon issued by Statutory Auditors of the Company.25-04-2023
Meghmani Finechem Ltd - 543332 - Board Meeting Outcome for Outcome Of Board Meeting - (1) Audited Financial Results (Standalone & Consolidated) For Quarter & Year Ended On 31St March, 2023 (2) Recommendation Of Final Dividend
Meghmani Finechem Limited informs that the Board of Directors at its meeting held today i.e. Tuesday, 25th April, 2023 has inter-alia transacted the following business: 1. Approved Audited (Standalone and Consolidated) Financial Results of the Company for the Quarter and Year ended on 31st March, 2023 and took on record Auditor's Report thereon issued by Statutory Auditors of the Company. A copy of the approved Audited Financial Results along with Auditor's Report is enclosed. We hereby declare and confirm that the Statutory Auditors of the Company, M/s S R B C & CO LLP, Chartered Accountants, have issued an unmodified Audit Report on the Audited Financial Results of the Company for the financial year ended 31st March 2023. 2. Recommended final dividend of Rs. 2.50 (25%) per equity share on 4,15,50,158 Equity Shares of Rs. 10/- each for the financial year ended 31st March, 2023, subject to approval of the Shareholders of the Company at the forthcoming Annual General Meeting.25-04-2023
Meghmani Finechem Ltd - 543332 - Q4 & FY23 Earnings Conference Call on 25th April, 2023
Meghmani Finechem Ltd has informed BSE regarding "Q4 & FY23 Earnings Conference Call on 25th April, 2023"18-04-2023
Meghmani Finechem Ltd - 543332 - Board Meeting Intimation for Intimation Of The Board Meeting Of Meghmani Finechem Limited Scheduled To Be Held On Tuesday, 25Th April, 2023 For Consideration & Approval Of Audited Financial Results And Recommendation Of Final Dividend, If Any.
Meghmani Finechem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2023 ,inter alia, to consider and approve Audited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Year ended on 31st March, 2023 and recommendation of Final Dividend, if any, on the Equity Shares.12-04-2023
Meghmani Finechem Ltd - 543332 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Meghmani Finechem Limited submits the Certificate Under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulation, 2018 for the Quarter ended 31.03.202312-04-2023